Advising Current Health on $400 million acquisition by Best Buy

On 12 October 2021, Best Buy announced it had signed an agreement to acquire Current Health for $400 million. Current Health is a leading care-at-home technology platform, bringing together remote patient monitoring, telehealth, and patient engagement into a single solution for healthcare organisations. 

Taylor Wessing represented Current Health in the acquisition alongside Wilson Sonsini Goodrich & Rosati.

Current Health’s enterprise care-at-home platform enables healthcare organisations to deliver high-quality, patient-centric care at a lower cost. 

The company integrates patient-reported data with data from biosensors – including their own continuous monitoring wearable device – to provide healthcare organisations with actionable, real-time insights into the patient’s condition. 

Leveraging clinical algorithms that can be tailored to the individual patient, Current Health identifies when a patient needs clinical attention, allowing organizations to manage patient care remotely or coordinate in-home care via its integrated service partners. 

The Current Health platform brings together telehealth capabilities, patient engagement tools, and in-home connectivity to provide a single solution to manage all care in the home.

The team advising Current Health was led by partner Howard Palmer, with support from partners Lauren Fendick, Anna Humphrey, Colin McCall, Graham Samuel-Gibbon, and Sian Skelton, senior associates Nabil Asaad, Sarah Cole, Georgina Wardrop, and James Watkins, and associates Joe Fallon, Edward Hadcock, Laura Mackie, Harry Ruffell, Emily Townsend, and Marianna Vlas.